PBX1 Is a Favorable Prognostic Biomarker as It Modulates 13- <i>cis</i> Retinoic Acid–Mediated Differentiation in Neuroblastoma
Nilay Shah(Imperial College London), Jeffrey A. Toretsky(Georgetown University), Julia Selich‐Anderson(Nationwide Children's Hospital), Hasan Siddiqui(Cancer Genetics (United States)), Xin Li(Hubei University of Medicine), Javed Khan(Kent State University), Jianjun Wang(Kunming University of Science and Technology), Garrett T. Graham(Georgetown University)
Cited by 23
Related Papers
Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks
|Nature Medicine|2001|2.7k
Comprehensive Genomic Analysis of Rhabdomyosarcoma Reveals a Landscape of Alterations Affecting a Common Genetic Axis in Fusion-Positive and Fusion-Negative Tumors
|Cancer Discovery|2014|789
Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome
|Blood|2011|638
Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations
|Nature Genetics|2015|563